1,427
Views
67
CrossRef citations to date
0
Altmetric
Brief Communication

Flubromazolam – A new life-threatening designer benzodiazepine

, , , , &
Pages 66-68 | Received 17 Aug 2015, Accepted 21 Oct 2015, Published online: 20 Nov 2015

References

  • O'Brien CP. Benzodiazepine use, abuse, and dependence. J Clin Psychiatry. 2005;66:28–33.
  • Moosmann B, Huppertz LM, Hutter M, et al. Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics. J Mass Spectrom. 2013;48:1150–1159.
  • Moodmann B, King AL, Auwärter V. Designer benzodiazepines: a new challenge. World Psychiatry. 2015;14:2.
  • Moosmann B, Bisel P, Auwärter V. Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics. Drug Test Anal. 2014;6:757–763.
  • Schifano F, Orsolini L, Papanti GD, et al. Novel psychoactive substances of interest for psychiatry. World Psychiatry. 2015;14:15–26.
  • Nakamae T, Shinozuka T, Sasaki C, et al. Case report: etizolam and its major metabolites in two unnatural death cases. Forensic Sci Int. 2008;20:182.
  • Laloup M, Ramirez Fernandez Mdel M, De Boeck G, et al. Validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous determination of 26 benzodiazepines and metabolites, zolpidem and zopiclone in blood, urine, and hair. J Anal Toxicol. 2005;29:616–626.
  • Aljarallah S, Al-Hussain F. Acute fatal posthypoxic leukoencephalopathy following benzodiazepine overdose: a case report and review of the literature. BMC Neurol. 2015;15:69.
  • [cited 2015 Sep 15]. Available from: http://tripbot.tripsit.me/factsheet/Flubromazolam.
  • Huppertz LM, Bisel P, Westphal F, et al. Characterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam and meclonazepam and identification of their in vitro metabolites. Forensic Toxicol. 2015;33:388–395.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.